A study published in Nature Materials detailed the unique method by which breast cancer cells break out and become invasive. They found that cancer cells work as a group to physically deform and tear through the basement membrane barrier. Read more: learn-more.com/883bv

So proud to share this work with The Leukemia & Lymphoma Society to educate on the process through the lab, in hopes of empowering and mitigating the anxiety associated with the diagnostic process and time needed to get results. linkedin.com/posts/seongchi…

If you're 45 or older, get screened! Learn more at YourColonIs45.org 🙌

Today is the beginning of March Colon Cancer Awareness Month. Join the Colorectal Cancer Alliance in ending this disease in our lifetime.

Check out this message from Colorectal Cancer Alliance CEO, Michael Sapienza 👇 #ColorectalCancerAwarenessMonth #DressInBlueDay

What my colleagues saw today on my calls… #DressInBlueDay #ColorectalCancerAwarenessMonth Colorectal Cancer Alliance Cure GI Cancers More to come this month!

June is officially Alzheimer’s and Brain Awareness Month. Discover three ways you can help your employees potentially reduce their risk of developing Alzheimer’s and dementia. pbynd.co/zm7rb

Labcorp is proud to support the 21st International Symposium on Pediatric Neuro-Oncology (ISPNO) hosted by the Children’s Hospital of Philadelphia Brain Tumor Program. Register and attend ISPNO pbynd.co/6vm53

Comprehensive biomarker testing like CGIP can uncover key molecular and immune targets in a patient’s tumor. This allows for effective personalized treatment options and potential clinical trial opportunities for patients with #cancer. Learn more: oncology.labcorp.com/cancer-care-te…

Uncertain about HER2 testing in GI cancers? This Seminars & Tumor Board activity delves into that & more! Expert panelists discuss treatment for gastric, colorectal & biliary tract cancers 👉 bit.ly/48azjin Developed in collaboration with PeerView and Cholangiocarcinoma Foundation

Researchers have identified human gut bacteria that produce an enzyme that can change artery-clogging cholesterol into a less harmful version that the body is unable to absorb. The results suggest potential therapies for hypercholesterolemia. Read more: pbynd.co/875ad

Labcorp’s Global Internship program is designed to provide current students the opportunity to explore diverse career opportunities through meaningful projects, hands-on real world work, network exposure, professional development and mentorship. Join us: pbynd.co/nvnej

We are proud to have earned a top score on the 2024 Disability Equality Index®, and to be recognized by Disability:IN as a #BestPlaceToWork24 for #DisabilityInclusion. Read the full news release: spr.ly/6048ikjig

Today is #WorldLungCancerDay. Did you know smoking tobacco increases an individual's risk of developing 17 types of cancers in addition to lung cancer? Learn about ways to reduce the burden of cancer in the AACR #CancerProgressReport. bit.ly/3SrCRaD #WLCD24

T-DXd is approved for patients with any HER2+ solid tumor (IHC 3+ on tissue) Could ctDNA also allow to identify pts benefiting from T-DXd? In the HERALD trial, 62 pts with 16 cancer types having ctDNA-detected HER2 amplifications received T-DXd ORR 56% ascopubs.org/doi/10.1200/JC…

Experts say one age group has seen an overall rise in cancer rates: younger Americans. “Early onset colorectal cancer, I think, was the canary in the coal mine here,” Karen Knudsen, MBA PhD tells William Brangham. "We know that early detection saves lives."

linkedin.com/posts/hibageor…

Unlock the three keys to drug discovery success. Learn how Labcorp’s foresight, hindsight and insight can help you sidestep challenges and discover the one: labcorp.com/unlock-3-keys-…

Scientists have recently discovered thousands of active RNA molecules that can control the human body. Read more. pbynd.co/nkgct

This cohort study characterizes temporal changes in plasma biomarkers, identifies factors associated with changes in plasma biomarkers over time, and evaluates the prospective associations of plasma biomarkers with late-life all-cause dementia. Read more: jamanetwork.com/journals/jama/…